Research points to fructose and brain inflammation as central triggers for weight gain

New scientific research is redefining understanding of the causes of obesity, shifting the exclusive focus from fats and carbohydrates to a specific type of sugar: fructose. A study conducted by researchers at Universidade of Colorado points out that fructose, present in foods such as corn syrup and table sugar, plays a crucial role in weight gain by altering the body’s energy metabolism.
The central hypothesis is that the metabolization of fructose reduces the active energy available to cells, a state that the body interprets as hunger. Essa signaling triggers an increase in appetite and food intake, creating a cycle that favors fat accumulation and makes weight loss difficult, regardless of total calorie count.
In parallel, scientists at Universidade at Basileia at Este process, in turn, directly interferes with insulin production, adding a complex neurological layer to the debate about weight control.
The mechanism of fructose in the body
According to Richard Johnson, one of the study’s lead researchers, when fructose is processed by the body, it effectively puts the metabolism into a “low consumption mode.” Isso means that active energy, known as ATP, decreases, signaling to the brain the need to seek more fuel for the cells.
This induced hunger leads to the search for high-calorie foods, such as those rich in fat. However, fructose itself prevents ingested fat from being used to replenish active energy, directing it to storage. The result is a vicious cycle of hunger and fat accumulation, despite calorie intake.
The analogy with animal hibernation
To illustrate this theory, researchers use the example of animals that hibernate, such as bears. Antes of winter, these animals consume large quantities of fruits rich in fructose. Esse consumption is not just to accumulate calories, but to activate a metabolic switch that promotes intensive fat storage in preparation for the long period of dormancy. Fructose, in this context, is the trigger that signals the body to go into survival mode and store energy. “Essentially, these theories [about consumption of fatty foods and carbohydrates being responsible for weight gain] cast metabolic and dietary factors at the heart of the obesity epidemic. weight gain”, explains Johnson. The theory proposes that human obesity can be viewed as a similar state of low energy, where the body is constantly trying to store, rather than utilize, consumed nutrients.
Brain response and the role of insulin
The Swiss research, published in the journal Cell Metabolism, deepens understanding of the so-called “cephalic phase” of digestion. Esse phenomenon describes the physiological reactions that occur in the body just in anticipation of a meal.
The central discovery was the identification of a specific inflammatory factor, interleukin 1 beta (IL1B), which is released in the brain when a person sees or smells food. Até then, IL1B was mainly associated with immune responses against pathogens or tissue damage.
This brain inflammatory factor sends a direct signal to the pancreas, stimulating insulin production. The revelation that an inflammatory process is involved in normal insulin regulation in healthy individuals surprised the scientific community.
The Connection to Type 2 Diabetes
The surprise of the researchers, led by Marc Donath, is due to the fact that IL1B is also directly involved in the development of type 2 diabetes.
In healthy people, the IL1B signal generated by the anticipation of food is beneficial, preparing the body to receive and process glucose from the meal. The nervous system retransmits the signal in a controlled manner to facilitate hormonal secretion.
However, in studies with animal models and obese humans, scientists observed that this signaling was impaired. Excessive inflammation, common in obesity, interrupts the adequate regulation of insulin secretion during the cephalic phase.
This dysfunction means that the body cannot adequately prepare for the arrival of nutrients, which can contribute to insulin resistance and, eventually, the development of type 2 diabetes.
Implications for future treatments
The results of the Swiss research open up new possibilities for the treatment of diabetes. The identification of IL1B as a key mediator in insulin secretion suggests that medications that inhibit this inflammatory factor could be used to restore adequate pancreatic function. Scientists now plan to explore this hypothesis through further clinical studies, focusing on an approach that combines neurology and endocrinology to combat metabolic disease.
This new research front becomes even more relevant given the global scenario. Organização Mundial of the Saúde (WHO) warns that cases of diabetes have quadrupled in the last four decades. Dados of Federação Internacional of
New perspectives on weight gain
Taken together, the studies indicate that obesity is a much more complex phenomenon than the simple math of calories consumed versus calories expended. Fatores how the type of nutrient ingested and the body’s neurological responses play determining roles in the process.
The carbohydrate debate
The fructose theory also highlights that the human body can produce this substance internally from the ingestion of other carbohydrates, especially those with a high glycemic index, such as white bread and potatoes.
This broadens the debate about low-carb diets, suggesting that weight management may depend not only on reducing added sugars, but also on the overall quality of carbohydrates consumed and their impact on energy metabolism.






